amphetamine has been researched along with Child Mental Disorders in 3 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We measured cell distribution in striatum and cortex by histology and microtomography, and quantified the basal and amphetamine-stimulated locomotion and nuclear-distribution element-like 1 activity (in blood and brain) of transgenic disrupted-in-schizophrenia 1 rat vs wild-type littermate controls." | 7.96 | Decreased nuclear distribution nudE-like 1 enzyme activity in an animal model with dysfunctional disrupted-in-schizophrenia 1 signaling featuring aberrant neurodevelopment and amphetamine-supersensitivity. ( Cruz, FC; Dias, CS; Engi, SA; Fonseca, MC; Gazarini, ML; Hayashi, MA; Korth, C; Nani, JV; Perillo, MG, 2020) |
| "We measured cell distribution in striatum and cortex by histology and microtomography, and quantified the basal and amphetamine-stimulated locomotion and nuclear-distribution element-like 1 activity (in blood and brain) of transgenic disrupted-in-schizophrenia 1 rat vs wild-type littermate controls." | 3.96 | Decreased nuclear distribution nudE-like 1 enzyme activity in an animal model with dysfunctional disrupted-in-schizophrenia 1 signaling featuring aberrant neurodevelopment and amphetamine-supersensitivity. ( Cruz, FC; Dias, CS; Engi, SA; Fonseca, MC; Gazarini, ML; Hayashi, MA; Korth, C; Nani, JV; Perillo, MG, 2020) |
| "Oxytocin has been suggested as a promising new treatment for neurodevelopmental disorders." | 3.81 | The Effect of Oxytocin on Social and Non-Social Behaviour and Striatal Protein Expression in C57BL/6N Mice. ( Bu, B; Chua, SE; Lam, S; Li, Q; McAlonan, GM; Sham, PC; Wang, W; Zhang, M; Zhang, X, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nani, JV | 1 |
| Fonseca, MC | 1 |
| Engi, SA | 1 |
| Perillo, MG | 1 |
| Dias, CS | 1 |
| Gazarini, ML | 1 |
| Korth, C | 2 |
| Cruz, FC | 1 |
| Hayashi, MA | 1 |
| Zhang, X | 1 |
| Li, Q | 1 |
| Zhang, M | 1 |
| Lam, S | 1 |
| Sham, PC | 1 |
| Bu, B | 1 |
| Chua, SE | 1 |
| Wang, W | 1 |
| McAlonan, GM | 1 |
| Vomund, S | 1 |
| de Souza Silva, MA | 1 |
| Huston, JP | 1 |
3 other studies available for amphetamine and Child Mental Disorders
| Article | Year |
|---|---|
Decreased nuclear distribution nudE-like 1 enzyme activity in an animal model with dysfunctional disrupted-in-schizophrenia 1 signaling featuring aberrant neurodevelopment and amphetamine-supersensitivity.
Topics: Amphetamine; Animals; Animals, Genetically Modified; Brain; Cell Count; Cell Nucleus; Central Nervou | 2020 |
The Effect of Oxytocin on Social and Non-Social Behaviour and Striatal Protein Expression in C57BL/6N Mice.
Topics: Amphetamine; Animals; Dopamine; Female; Male; Mice; Mice, Inbred C57BL; Neostriatum; Neurodevelopmen | 2015 |
Behavioral Resilience and Sensitivity to Locally Restricted Cortical Migration Deficits Induced by In Utero Knockdown of Disabled-1 in the Adult Rat.
Topics: Adaptor Proteins, Signal Transducing; Amphetamine; Animals; Cell Line, Tumor; Cell Movement; Central | 2017 |